Grenville Peter Hadley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Grenville Peter Hadley has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
M. Mars
Department of TeleHealth, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
4 shared publications- Barry van Emmenes
Department of Paediatrics, Division of Paediatric Haematology and Oncology Frere Hospital East London South Africa
3 shared publications - Gita Naidu
Paediatric Oncology Unit, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
3 shared publications - Jaques van Heerden
Department of Paediatric Haemato-Oncology, MIPRO Laboratory, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium
3 shared publications - Marc Hendricks
University of Cape Town
3 shared publications - Mariana Kruger
Stellenbosch University
3 shared publications
Latest Publications
- 23 January 2021
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (4) , e28878
Age at diagnosis as a prognostic factor in South African children with neuroblastoma
Purpose: Low‐ and middle‐income countries (LMICs) reported a higher median age at diagnosis of neuroblastoma (NB) compared to high‐income countries. The aim was to determine if the optimal age at diagnosis, which maximizes the difference in overall survival between younger versus older patients in the South African population was similar to the internationally validated 18 months age cut‐point.Methods: Four hundred sixty NB patients diagnosed between 2000 and 2016 were included. Receiver operating characteristic (ROC) curves were used to predict potential age cut‐point values for overall survival in all risk group classifications. Risk ratios, sensitivity, specificity, and positive and negative predictive values at the specific cut‐points were estimated with 95% confidence intervals, and time to mortality by age at the specific cut‐points was shown with Kaplan‐Meier curves and compared using log‐rank tests.Results: The median age at diagnosis for the total cohort was 31.9 months (range 0.2‐204.7). For high‐risk (HR), intermediate‐risk, low‐risk, and very low‐risk patients, the median age at diagnosis was, respectively, 36 months (range 0.4‐204.7), 16.8 months (range 0.7‐145.1), 14.2 months (range 2.0‐143.5), and 8.7 months (range 0.2‐75.6). The ROC curves for the total NB cohort (area under the curve [AUC] 0.696; P < .001) and HR (AUC 0.682; P < .001) were analyzed further. The optimal cut‐point value for the total cohort was at 19.1 months (sensitivity 59%; specificity 78%). The HR cohort had potential cut‐point values identified at 18.4 months age at diagnosis (sensitivity 45%; specificity 87%) and 31.1 months (sensitivity 67%; specificity 62%). The 19.1 months cut‐point value in the total cohort and the 18.4 months cut‐point value in HR were as useful in predicting overall survival as 18 months age at diagnosis.Conclusion: The 18 months cut‐point value appears to be the appropriate age for prognostic determination, despite the higher median age at diagnosis in South Africa.
- 23 January 2021
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (4) , e28878
Age at diagnosis as a prognostic factor in South African children with neuroblastoma
Purpose: Low‐ and middle‐income countries (LMICs) reported a higher median age at diagnosis of neuroblastoma (NB) compared to high‐income countries. The aim was to determine if the optimal age at diagnosis, which maximizes the difference in overall survival between younger versus older patients in the South African population was similar to the internationally validated 18 months age cut‐point.Methods: Four hundred sixty NB patients diagnosed between 2000 and 2016 were included. Receiver operating characteristic (ROC) curves were used to predict potential age cut‐point values for overall survival in all risk group classifications. Risk ratios, sensitivity, specificity, and positive and negative predictive values at the specific cut‐points were estimated with 95% confidence intervals, and time to mortality by age at the specific cut‐points was shown with Kaplan‐Meier curves and compared using log‐rank tests.Results: The median age at diagnosis for the total cohort was 31.9 months (range 0.2‐204.7). For high‐risk (HR), intermediate‐risk, low‐risk, and very low‐risk patients, the median age at diagnosis was, respectively, 36 months (range 0.4‐204.7), 16.8 months (range 0.7‐145.1), 14.2 months (range 2.0‐143.5), and 8.7 months (range 0.2‐75.6). The ROC curves for the total NB cohort (area under the curve [AUC] 0.696; P < .001) and HR (AUC 0.682; P < .001) were analyzed further. The optimal cut‐point value for the total cohort was at 19.1 months (sensitivity 59%; specificity 78%). The HR cohort had potential cut‐point values identified at 18.4 months age at diagnosis (sensitivity 45%; specificity 87%) and 31.1 months (sensitivity 67%; specificity 62%). The 19.1 months cut‐point value in the total cohort and the 18.4 months cut‐point value in HR were as useful in predicting overall survival as 18 months age at diagnosis.Conclusion: The 18 months cut‐point value appears to be the appropriate age for prognostic determination, despite the higher median age at diagnosis in South Africa.
- 19 February 2020
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 37 (4) , 300-313
The evaluation of induction chemotherapy regimens for high-risk neuroblastoma in South African children *
Achieving remission after induction therapy in high-risk neuroblastoma (HR-NB) is of significant prognostic importance. This study investigated remission after induction-chemotherapy using three standard neuroblastoma protocols in the South African (SA) setting. Retrospective data of 261 patients with HR-NB diagnosed between January 2000 and December 2016, who completed induction chemotherapy with standard treatment protocols were evaluated. The treatment protocols were either OPEC/OJEC or the St Jude NB84 protocol (NB84) or rapid COJEC (rCOJEC). The postinduction metastatic complete remission (mCR) rate, 2-year overall survival (OS) and 2-year event free survival (EFS) were determined as comparative denominators. The majority (48.3%; n = 126) received OPEC/OJEC, while 70 patients received (26.8%) rCOJEC and 65 (24.9%) NB84. Treatment with NB84 had the best mCR rate (36.9%), followed by OPEC/OJEC (32.5%) and rCOJEC (21.4%). The 2-year OS of treatment with NB84 was 41% compared to OPEC/OJEC (35%) and rCOJEC (24%) (p = 0.010). The 2-year EFS of treatment with NB84 was 37% compared to OPEC/OJEC (35%) and rCOJEC (18%) (p = 0.008). OPEC/OJEC had the least treatment-related deaths (1.6%) compared to rCOJEC (7.1%) and NB84 (7.5%) (p = 0.037). On multivariate analysis LDH (p = 0.023), ferritin (p = 0.002) and INSS stage (p = 0.006) were identified as significant prognostic factors for OS. The induction chemotherapy was not significant for OS (p = 0.18), but significant for EFS (p = 0.08) Treatment with NB84 achieved better mCR, OS and EFS, while OPEC/OJEC had the least treatment-related deaths. In resource-constrained settings, OPEC/OJEC is advised as induction chemotherapy in HR-NB due to less toxicity as reflected in less treatment-related deaths.
- 19 February 2020
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 37 (4) , 300-313
The evaluation of induction chemotherapy regimens for high-risk neuroblastoma in South African children *
Achieving remission after induction therapy in high-risk neuroblastoma (HR-NB) is of significant prognostic importance. This study investigated remission after induction-chemotherapy using three standard neuroblastoma protocols in the South African (SA) setting. Retrospective data of 261 patients with HR-NB diagnosed between January 2000 and December 2016, who completed induction chemotherapy with standard treatment protocols were evaluated. The treatment protocols were either OPEC/OJEC or the St Jude NB84 protocol (NB84) or rapid COJEC (rCOJEC). The postinduction metastatic complete remission (mCR) rate, 2-year overall survival (OS) and 2-year event free survival (EFS) were determined as comparative denominators. The majority (48.3%; n = 126) received OPEC/OJEC, while 70 patients received (26.8%) rCOJEC and 65 (24.9%) NB84. Treatment with NB84 had the best mCR rate (36.9%), followed by OPEC/OJEC (32.5%) and rCOJEC (21.4%). The 2-year OS of treatment with NB84 was 41% compared to OPEC/OJEC (35%) and rCOJEC (24%) (p = 0.010). The 2-year EFS of treatment with NB84 was 37% compared to OPEC/OJEC (35%) and rCOJEC (18%) (p = 0.008). OPEC/OJEC had the least treatment-related deaths (1.6%) compared to rCOJEC (7.1%) and NB84 (7.5%) (p = 0.037). On multivariate analysis LDH (p = 0.023), ferritin (p = 0.002) and INSS stage (p = 0.006) were identified as significant prognostic factors for OS. The induction chemotherapy was not significant for OS (p = 0.18), but significant for EFS (p = 0.08) Treatment with NB84 achieved better mCR, OS and EFS, while OPEC/OJEC had the least treatment-related deaths. In resource-constrained settings, OPEC/OJEC is advised as induction chemotherapy in HR-NB due to less toxicity as reflected in less treatment-related deaths.
- Open Access
- 31 July 2019
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 66 (11) , e27944
Overall survival for neuroblastoma in South Africa between 2000 and 2014
Background: Outcome data for neuroblastoma in sub‐Saharan Africa are minimal, whereas poor outcome is reported in low‐ and middle‐income countries. A multi‐institutional retrospective study across South Africa was undertaken to determine outcome.Methods: Patients treated between January 2000 and December 2014 in nine South African pediatric oncology units were included. Kaplan–Meier curves and Cox regression models were employed to determine two‐year survival rates and to identify prognostic factors.Results: Data from 390 patients were analyzed. The median age was 39.9 months (range, 0–201 months). The majority presented with stage 4 disease (70%). The main chemotherapy regimens were OPEC/OJEC (44.8%), St Jude NB84 protocol (28.96%), and Rapid COJEC (22.17%). Only 44.4% had surgery across all risk groups, whereas only 16.5% of high‐risk patients received radiotherapy. The two‐year overall survival (OS) for the whole cohort was 37.6%: 94.1%, 81.6%, and 66.7%, respectively, for the very‐low‐risk, low‐risk, and intermediate‐risk groups and 27.6% for the high‐risk group (P < 0.001, 95% CI). The median survival time for the whole group was 13 months (mean, 41.9 months; range, 0.1–209 months). MYCN‐nonamplified patients had a superior two‐year OS of 51.3% in comparison with MYCN‐amplified patients at 37.3% (P = 0.002, 95% CI).Conclusions: Limited disease had an OS comparable with high‐income countries, but advanced disease had a poor OS. South Africa should focus on early diagnosis and implementation of a national protocol with equitable access to treatment.
- 31 July 2019
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 66 (11) , e27944
Open AccessOverall survival for neuroblastoma in South Africa between 2000 and 2014
Background: Outcome data for neuroblastoma in sub‐Saharan Africa are minimal, whereas poor outcome is reported in low‐ and middle‐income countries. A multi‐institutional retrospective study across South Africa was undertaken to determine outcome.Methods: Patients treated between January 2000 and December 2014 in nine South African pediatric oncology units were included. Kaplan–Meier curves and Cox regression models were employed to determine two‐year survival rates and to identify prognostic factors.Results: Data from 390 patients were analyzed. The median age was 39.9 months (range, 0–201 months). The majority presented with stage 4 disease (70%). The main chemotherapy regimens were OPEC/OJEC (44.8%), St Jude NB84 protocol (28.96%), and Rapid COJEC (22.17%). Only 44.4% had surgery across all risk groups, whereas only 16.5% of high‐risk patients received radiotherapy. The two‐year overall survival (OS) for the whole cohort was 37.6%: 94.1%, 81.6%, and 66.7%, respectively, for the very‐low‐risk, low‐risk, and intermediate‐risk groups and 27.6% for the high‐risk group (P < 0.001, 95% CI). The median survival time for the whole group was 13 months (mean, 41.9 months; range, 0.1–209 months). MYCN‐nonamplified patients had a superior two‐year OS of 51.3% in comparison with MYCN‐amplified patients at 37.3% (P = 0.002, 95% CI).Conclusions: Limited disease had an OS comparable with high‐income countries, but advanced disease had a poor OS. South Africa should focus on early diagnosis and implementation of a national protocol with equitable access to treatment.
- Open Access
- 26 March 2015
- Published by Hindawi Limited in International Journal of Pediatrics
- Vol. 2015, 1-5
The Impact of Ethnicity on Wilms Tumor: Characteristics and Outcome of a South African Cohort
Background. Nephroblastoma is the commonest renal tumour seen in children. It has a good prognosis in developed countries with survival rates estimated to be between 80% and 90%, while in Africa it remains low.Method. Retrospective study of patients diagnosed with nephroblastoma who are seen at 4 paediatric oncology units, representing 58.5% of all South African children with nephroblastoma and treated following SIOP protocol between January 2000 and December 2010.Results. A total of 416 patients were seen at the 4 units. Over 80% of our patients were African and almost 10% of mixed ethnicity. The most common stage was stage 4. The median survival was 28 months after diagnosis with the mixed ethnicity patients recording the longest duration (39 months) and the white patients had the shortest median survival. The overall 5-year survival rate was estimated to be 66%. Stage 2 patients did significantly better (85%).Conclusions. Our patients are similar with regard to gender ratio, median age, and age distribution as described in the literature, but in South Africa the more advanced stage disease seen than in other developed countries is translated into low overall survival rate.
- 26 March 2015
- Published by Hindawi Limited in International Journal of Pediatrics
- Vol. 2015, 1-5
Open AccessThe Impact of Ethnicity on Wilms Tumor: Characteristics and Outcome of a South African Cohort
Background. Nephroblastoma is the commonest renal tumour seen in children. It has a good prognosis in developed countries with survival rates estimated to be between 80% and 90%, while in Africa it remains low.Method. Retrospective study of patients diagnosed with nephroblastoma who are seen at 4 paediatric oncology units, representing 58.5% of all South African children with nephroblastoma and treated following SIOP protocol between January 2000 and December 2010.Results. A total of 416 patients were seen at the 4 units. Over 80% of our patients were African and almost 10% of mixed ethnicity. The most common stage was stage 4. The median survival was 28 months after diagnosis with the mixed ethnicity patients recording the longest duration (39 months) and the white patients had the shortest median survival. The overall 5-year survival rate was estimated to be 66%. Stage 2 patients did significantly better (85%).Conclusions. Our patients are similar with regard to gender ratio, median age, and age distribution as described in the literature, but in South Africa the more advanced stage disease seen than in other developed countries is translated into low overall survival rate.
- 1 December 2014
- Published by Elsevier in Seminars in Pediatric Surgery
- Vol. 23 (6) , 357-362
Intra-abdominal sepsis—Epidemiology, aetiology and management
- 1 December 2014
- Published by Elsevier in Seminars in Pediatric Surgery
- Vol. 23 (6) , 357-362
Intra-abdominal sepsis—Epidemiology, aetiology and management
- 22 January 2014
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 61 (6) , 987-989
Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa
- 22 January 2014
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 61 (6) , 987-989
Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa
- 2 March 2013
- Published by Springer Nature in Pediatric Surgery International
- Vol. 29 (5) , 419-423
Bilateral Wilms’ tumour in a developing country: a descriptive study
Purpose To present our experience of 20 children with bilateral Wilms’ tumour seen in a resource-challenged environment over a 10-year period. Method All patients with a diagnosis of bilateral synchronous Wilms’ tumour were identified and recruited. Results Study patients represented 11 % of a cohort of 177 new patients with Wilms’ tumour seen over the same period. Three patients had a syndromic predisposition to Wilms’ tumour. Metastatic disease was seen at presentation in four patients (20 %) and three children presented with unilateral tumour rupture. One patient presented with paraplegia and one with obstruction of the duodenum. All children received neoadjuvant chemotherapy. One HIV-infected child died of IRIS after neoadjuvant treatment, but before surgery. One child died of progressive disease after unilateral nephrectomy. Nephron-sparing surgery was performed in 22 kidneys and 15 kidneys were removed in toto. Following enucleation of tumours, three children had positive margins. Discordant histopathology was seen in 53 % of patients. Overall survival at 2 years is 85 %. Conclusion Despite significant co-morbidity and advanced disease, bilateral Wilms’ tumour is a treatable disease in a resource-constrained environment.
- 2 March 2013
- Published by Springer Nature in Pediatric Surgery International
- Vol. 29 (5) , 419-423
Bilateral Wilms’ tumour in a developing country: a descriptive study
Purpose To present our experience of 20 children with bilateral Wilms’ tumour seen in a resource-challenged environment over a 10-year period. Method All patients with a diagnosis of bilateral synchronous Wilms’ tumour were identified and recruited. Results Study patients represented 11 % of a cohort of 177 new patients with Wilms’ tumour seen over the same period. Three patients had a syndromic predisposition to Wilms’ tumour. Metastatic disease was seen at presentation in four patients (20 %) and three children presented with unilateral tumour rupture. One patient presented with paraplegia and one with obstruction of the duodenum. All children received neoadjuvant chemotherapy. One HIV-infected child died of IRIS after neoadjuvant treatment, but before surgery. One child died of progressive disease after unilateral nephrectomy. Nephron-sparing surgery was performed in 22 kidneys and 15 kidneys were removed in toto. Following enucleation of tumours, three children had positive margins. Discordant histopathology was seen in 53 % of patients. Overall survival at 2 years is 85 %. Conclusion Despite significant co-morbidity and advanced disease, bilateral Wilms’ tumour is a treatable disease in a resource-constrained environment.
- 1 May 2012
- Published by Elsevier in Seminars in Pediatric Surgery
- Vol. 21 (2) , 136-141
Challenge of pediatric oncology in Africa
- 1 May 2012
- Published by Elsevier in Seminars in Pediatric Surgery
- Vol. 21 (2) , 136-141
Challenge of pediatric oncology in Africa
- 21 November 2010
- Published by Springer Nature in Pediatric Surgery International
- Vol. 27 (4) , 407-410
e-Education in paediatric surgery: a role for recorded seminars in areas of low bandwidth in sub-Saharan Africa
Background There is a shortage of surgeons in Africa, and this shortage is particularly acute in paediatric surgery with most paediatric patients being cared for by general surgeons. The use of information technology to augment teaching in paediatric surgery in Africa is appealing but often unsuccessful due to the costs involved and a lack of bandwidth. A simple solution is needed to allow sharing of teaching sessions that are normally conducted by videoconference in areas in which bandwidth is adequate. Method Weekly paediatric surgical interactive seminars that are regularly shared by videoconference by three centres in South Africa have been recorded onto DVDs. These have been bundled into monthly packages and couriered to four medical schools in East and Central Africa. Recipients have been at liberty to use them as they saw fit. After 6 months, a survey was conducted to determine the usefulness of the exercise. Results At all recipient sites, the seminars were used as part of the teaching of general surgical trainees and paediatric surgical fellows at those medical schools with appropriate training programmes. Three of the four schools used the seminars in undergraduate courses. All regarded the seminars as useful and all but one as of adequate visual and sound quality. Conclusion The in-house teaching at the medical school in Durban is now shared by over 140 surgical trainees and students in four countries in which a lack of bandwidth precludes videoconferencing, and this low-tech low-cost solution has proved effective in resource-poor settings.
- 21 November 2010
- Published by Springer Nature in Pediatric Surgery International
- Vol. 27 (4) , 407-410
e-Education in paediatric surgery: a role for recorded seminars in areas of low bandwidth in sub-Saharan Africa
Background There is a shortage of surgeons in Africa, and this shortage is particularly acute in paediatric surgery with most paediatric patients being cared for by general surgeons. The use of information technology to augment teaching in paediatric surgery in Africa is appealing but often unsuccessful due to the costs involved and a lack of bandwidth. A simple solution is needed to allow sharing of teaching sessions that are normally conducted by videoconference in areas in which bandwidth is adequate. Method Weekly paediatric surgical interactive seminars that are regularly shared by videoconference by three centres in South Africa have been recorded onto DVDs. These have been bundled into monthly packages and couriered to four medical schools in East and Central Africa. Recipients have been at liberty to use them as they saw fit. After 6 months, a survey was conducted to determine the usefulness of the exercise. Results At all recipient sites, the seminars were used as part of the teaching of general surgical trainees and paediatric surgical fellows at those medical schools with appropriate training programmes. Three of the four schools used the seminars in undergraduate courses. All regarded the seminars as useful and all but one as of adequate visual and sound quality. Conclusion The in-house teaching at the medical school in Durban is now shared by over 140 surgical trainees and students in four countries in which a lack of bandwidth precludes videoconferencing, and this low-tech low-cost solution has proved effective in resource-poor settings.
- 10 August 2010
- Published by Springer Nature in Pediatric Surgery International
- Vol. 26 (12) , 1169-1172
The management of nephroblastoma with cavo-atrial disease at presentation: experience from a developing country
- 10 August 2010
- Published by Springer Nature in Pediatric Surgery International
- Vol. 26 (12) , 1169-1172
The management of nephroblastoma with cavo-atrial disease at presentation: experience from a developing country